DE60235097D1 - Verfahren zur induktion einer selektiv unterdrückten immunantwort - Google Patents

Verfahren zur induktion einer selektiv unterdrückten immunantwort

Info

Publication number
DE60235097D1
DE60235097D1 DE60235097T DE60235097T DE60235097D1 DE 60235097 D1 DE60235097 D1 DE 60235097D1 DE 60235097 T DE60235097 T DE 60235097T DE 60235097 T DE60235097 T DE 60235097T DE 60235097 D1 DE60235097 D1 DE 60235097D1
Authority
DE
Germany
Prior art keywords
cells
blood
recipient
skin
induce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235097T
Other languages
English (en)
Inventor
Richard L Edelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Application granted granted Critical
Publication of DE60235097D1 publication Critical patent/DE60235097D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DE60235097T 2001-08-13 2002-08-13 Verfahren zur induktion einer selektiv unterdrückten immunantwort Expired - Lifetime DE60235097D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31200401P 2001-08-13 2001-08-13
PCT/US2002/025703 WO2003015850A1 (en) 2001-08-13 2002-08-13 Method for inducing selectively suppressed immune response

Publications (1)

Publication Number Publication Date
DE60235097D1 true DE60235097D1 (de) 2010-03-04

Family

ID=23209429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235097T Expired - Lifetime DE60235097D1 (de) 2001-08-13 2002-08-13 Verfahren zur induktion einer selektiv unterdrückten immunantwort

Country Status (7)

Country Link
US (2) US7625557B2 (de)
EP (1) EP1427462B1 (de)
AT (1) ATE454895T1 (de)
CA (1) CA2457015C (de)
DE (1) DE60235097D1 (de)
ES (1) ES2339752T3 (de)
WO (1) WO2003015850A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7727523B2 (en) * 2001-08-13 2010-06-01 Yale University Method for suppressing immune system response to transplanted tissue or cells
EP1990055A3 (de) * 2001-11-29 2011-11-16 Therakos, Inc. Verfahren zur Vorbehandlung einer Person durch extrakorporale Photopherese und/oder apoptotische Zellen
AU2004237844B2 (en) * 2003-12-23 2011-01-27 Therakos, Inc. Extracorporeal photopheresis in combination with anti-TNF treatment
AU2013353573B2 (en) 2012-12-06 2019-01-17 Enlivex Therapeutics R&D Ltd Therapeutic apoptotic cell preparations, method for producing same and uses thereof
US20160114095A1 (en) * 2014-10-27 2016-04-28 Fenwal, Inc. Methods and systems for collecting mononuclear cells
GB201513278D0 (en) * 2015-07-03 2015-09-09 Transimmune Ag And Yale University Device and method for obtaining immunostimulatory antigen-presenting cells
NZ746669A (en) * 2016-04-20 2022-10-28 New Frontier Labs Llc Azelaic acid esters in the treatment of insulin resistance
US11679193B2 (en) * 2017-12-20 2023-06-20 Fenwal, Inc. System and method of collecting and infusing an apoptotic white blood cell component and a transplant component
US20220214333A1 (en) * 2019-04-16 2022-07-07 Regents Of The University Of Minnesota Biomarker for transplantation tolerance induced by apoptotic donor leukocytes
WO2023006971A1 (en) * 2021-07-29 2023-02-02 Transimmune Ag Selective tolerization - methods of selectively generating tolerogenic dendritic cells

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US66021A (en) 1867-06-25 William edwin heath
US4321918A (en) * 1979-10-23 1982-03-30 Clark Ii William T Process for suppressing immunity to transplants
US4683889A (en) 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4838852A (en) * 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
US5167657A (en) 1988-11-14 1992-12-01 Baxter International Inc. Plastic composition with anti-hemolytic effect
US5147289A (en) 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement
DK16393D0 (da) 1993-02-12 1993-02-12 Silcon Power Electronics As Noedstroemsanlaeg
AU2331597A (en) * 1996-03-22 1997-10-10 Yale University Methods for inducing immune responsiveness in a subject
US6194204B1 (en) 1996-08-02 2001-02-27 Center For Blood Research, Inc. Enrichment of dendritic cells from blood
AU2872199A (en) * 1998-02-20 1999-09-06 Rockefeller University, The Apoptotic cell-mediated antigen presentation to dendritic cells
CA2321173A1 (en) * 1998-03-30 1999-10-07 I.D.M. Immuno-Designed Molecules Suppressive monocyte derived cells, process for their preparation and their uses in pharmaceutical compositions
US20050084966A1 (en) 1999-04-20 2005-04-21 Edelson Richard L. Methods for inducing the differentiation of blood monocytes into functional dendritic cells
AU782391B2 (en) * 1999-04-20 2005-07-21 Richard Leslie Edelson Differentiation of monocytes into functional dendritic cells
US6800300B1 (en) * 2000-03-31 2004-10-05 Vasogen Ireland Limited Method for treating autoimmune and alloimmune diseases
CA2309518A1 (en) * 2000-05-25 2001-11-25 Vasogen Ireland Limited Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
US7727523B2 (en) 2001-08-13 2010-06-01 Yale University Method for suppressing immune system response to transplanted tissue or cells

Also Published As

Publication number Publication date
ES2339752T3 (es) 2010-05-25
US7988951B2 (en) 2011-08-02
WO2003015850A1 (en) 2003-02-27
US20100183735A1 (en) 2010-07-22
EP1427462A1 (de) 2004-06-16
CA2457015A1 (en) 2003-02-27
CA2457015C (en) 2012-03-13
US20030059426A1 (en) 2003-03-27
ATE454895T1 (de) 2010-01-15
US7625557B2 (en) 2009-12-01
EP1427462A4 (de) 2006-06-07
EP1427462B1 (de) 2010-01-13

Similar Documents

Publication Publication Date Title
von Stebut et al. Cutaneous leishmaniasis: Distinct functions of dendritic cells and macrophages in the interaction of the host immune system with Leishmania major
Bogdan Natural killer cells in experimental and human leishmaniasis
Braun et al. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization
Wang et al. CD122+ CD8+ Treg suppress vaccine‐induced antitumor immune responses in lymphodepleted mice
DE60235097D1 (de) Verfahren zur induktion einer selektiv unterdrückten immunantwort
Liu et al. Plasmodium parasite as an effective hepatocellular carcinoma antigen glypican-3 delivery vector
AR068984A1 (es) Proceso para la obtencion de celulas presentadoras de antigenos activados, utiles en las terapias contra el cancer y enfermedades relacionadas del sistema inmunologico
EP1810691A3 (de) Immuntherapie zur Umkehrung einer Immunsuppression
Xia et al. High‐mobility group box 1 accelerates early acute allograft rejection via enhancing IL‐17+ γδ T‐cell response
He et al. Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes
Vallejo et al. Cellular pathway (s) of antigen processing in fish APC: effect of varying in vitro temperatures on antigen catabolism
Pinheiro et al. The T-cell anergy induced by Leishmania amazonensis antigens is related with defective antigen presentation and apoptosis
MX2022004186A (es) Composiciones y métodos in vitro para potenciar la activación de células dendríticas y células t, y para inducir una respuesta inmune th-1.
Thomson et al. Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance
Veltman et al. Low‐dose cyclophosphamide synergizes with dendritic cell‐based immunotherapy in antitumor activity
JP2014516538A5 (de)
NZ507829A (en) Vaccine adjuvants for immunotherapy of melanoma
Kautz‐Neu et al. Leishmaniasis, contact hypersensitivity and graft‐versus‐host disease: understanding the role of dendritic cell subsets in balancing skin immunity and tolerance
Froese et al. Brief communication: Neuraminidase-induced enhancement of tumor growth in mice
DE60329226D1 (de) Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate
US20210369774A1 (en) Micro-rna-155 enhances the efficacy of dendritic cell vaccine for cancer
Calderon-Gonzalez et al. Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma
WO2005009397A3 (en) Human lymphocyte vaccine adjuvant
WO2018015815A3 (en) Plasmodium with histamine releasing factor (hrf) deficiency for use as a vaccine
Yin et al. Antitumor efficacy of argon–helium cryoablation-generated dendritic cell vaccine in glioma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition